CHRONIC GRAFT VERSUS HOST DISEASE
Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach aims to spare kids from steroids in transplant complication
Disease control TerminatedThis study tested whether a drug called ruxolitinib could be used as the first treatment for chronic graft-versus-host disease (cGVHD) in children and young adults. The goal was to see if starting with ruxolitinib could control the disease while avoiding or reducing the need for …
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested to control dangerous transplant complication
Disease control TerminatedThis study tested whether adding the experimental drug itacitinib to standard steroid treatment could better control chronic graft-versus-host disease (cGVHD) in people who had stem cell transplants. Researchers enrolled 155 participants with moderate to severe cGVHD who hadn't r…
Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC